[1]Czajal AJ, Freese DK.Diagnosis and Treatment of AutoimmuneHepatitis[J].Hepatology, 2002, 36∶479-497.
|
[2]Choudhuri G, Somani SK, Baba CS, et al.Autoimmune hepatitis inIndia:profile of an uncommon disease[J].BMC Gastroenterol, 2005, 15∶27.
|
[3]Omagari K, Kinoshita H, Kato Y, et al.Clinical features of 89 pa-tients with autoimmune hepatitis in Nagasaki Prefecture, Japan[J].J Gastroenterol, 1999, 34∶221-226.
|
[1] | Guo DanDan, Tang ShaoShan. Value of advanced dynamic flow versus color Doppler flow imaging in evaluating stent patency after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(12): 2599-2602. doi: 10.3969/j.issn.1001-5256.2018.12.018 |
[2] | Zhao Bin, Ma ZhenQi. Serum levels of adiponectin and ferritin and their clinical significance in patients with nonalcoholic fatty liver in Qinghai,China[J]. Journal of Clinical Hepatology, 2016, 32(10): 1955-1958. doi: 10.3969/j.issn.1001-5256.2016.10.028 |
[3] | Feng QingLing, Feng ZeMin, Zhang ChunQing, Wang GuangChuan, Feng Hua. Effects of terlipressin and double- dose octreotide on hepatic venous pressure gradient in patients with liver cirrhosis:a comparative study[J]. Journal of Clinical Hepatology, 2016, 32(4): 720-723. doi: 10.3969/j.issn.1001-5256.2016.04.022 |
[4] | Zhang Yu, Cheng Jun. Hepatitis C virus related fatty liver[J]. Journal of Clinical Hepatology, 2015, 31(7): 1034-1037. doi: 10.3969/j.issn.1001-5256.2015.07.009 |
[5] | Xia YuLian, Zhang ChunQing, Wang GuangChuan, Feng Hua, Zhang MingYan. Individual and combined effects of octreotide and terlipressin on hepatic venous pressure gradient in cirrhotic patients[J]. Journal of Clinical Hepatology, 2015, 31(2): 214-218. doi: 10.3969/j.issn.1001-5256.2015.02.017 |
[6] | Shi JunPing, Xun YunHao. Progress in treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 890-893. doi: 10.3969/j.issn.1001-5256.2013.12.004 |
[7] | Tang JianJun, Jiang Yong, Luo GuangHua, Yuan Bo. The protective effect of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats[J]. Journal of Clinical Hepatology, 2011, 27(12): 1308-1311. |
[8] | Zhou ShuYun, Sun ZheYing. Therapeutic efficacy of polyunsaturated phosphatidylcholine on fatty liver disease[J]. Journal of Clinical Hepatology, 2010, 26(3): 286-287. |
[9] | Xiang GuoQing, Meng XiaoDan, Wang BingYuan. Prevalence of fatty liver among people with different occupation in Shenyang[J]. Journal of Clinical Hepatology, 2010, 26(3): 283-285. |
[10] | Xu YuWu, Liu YingZi, Fan JianGao, Yang Lin. Preliminary study on quantification of ultrasonographic classification of fatty liver [J]. Journal of Clinical Hepatology, 2010, 26(3): 267-268+280. |
[11] | Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166. |
[12] | Zhang FenMing, Gao SuQin, Kong DeZhi. Relationship between nonalcoholic fatty liver disease and insulin resistance in hypertensive patients[J]. Journal of Clinical Hepatology, 2007, 23(4): 277-279. |
[13] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[15] | Hu DeYou. Ultrasonic monitoring of relationship between exercise and fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(1): 34-35. |
[16] | Ding YanHua, He ShuMei, Wang XiaoWei, Xu MaoFeng, Niu JunQi. The clinical feature of 198 patients with fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(5): 287-288. |